Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
NPJ Systems Biology and Applications|November 7, 2024
Reliable and easy-to-use calculating tool for the Nail Psoriasis Severity Index using deep learningHiroto Horikawa, Keiji Tanese, Naoki Nonaka, et al.
The Oncologist|March 9, 2019
Combination Cisplatin-Epirubicin-Paclitaxel Therapy for Metastatic Extramammary Paget's DiseaseIkuko Hirai, Keiji Tanese, Yoshio Nakamura, et al.
The American Journal of Dermatopathology|September 23, 2009
Epstein-Barr virus-positive Hodgkin lymphoma-like earlobe lymphoid infiltrate: case reportKeiji Tanese, Rei Haratoh, Kozo Yamamoto, et al.
The Journal of Dermatology|April 25, 2021
Follicular extension of atypical keratinocytes predicts the resistance of actinic keratosis to topical imiquimod treatment: A single-center retrospective analysisRyo Tanaka, Keiji Tanese, Yingyao Zhu, et al.
In Vivo (Athens, Greece)|March 1, 2020
Metastatic Cutaneous Squamous Cell Carcinoma in Liver Successfully Treated With Partial Hepatectomy and Adjuvant Irinotecan ChemotherapyYasuhiko Asahina, Yoshio Nakamura, Keiji Tanese, et al.
The Journal of Dermatology|February 6, 2020
Weekly docetaxel monotherapy for metastatic extramammary Paget's disease: Retrospective single-institute analysisYoshio Nakamura, Keiji Tanese, Ikuko Hirai, et al.
Experimental Cell Research|November 7, 2012
Leucine-rich repeat-containing G protein-coupled receptor 5 regulates epithelial cell phenotype and survival of hepatocellular carcinoma cellsMariko Fukuma, Keiji Tanese, Kathryn Effendi, et al.
The Journal of Dermatology|November 1, 2018
High-grade trichoblastic carcinoma arising through malignant transformation of trichoblastoma: Immunohistochemical analysis and the expression of p53 and phosphorylated AKTTakayuki Fusumae, Keiji Tanese, Asako Takeuchi, et al.
Annals of Medicine|November 19, 2021
Stratification of atopic dermatitis patients by patterns of response to proactive therapy with topical tacrolimus: low serum IgE levels and inadequately controlled disease activity at the start of treatment predict its failureHiroko Kasai, Hiroshi Kawasaki, Ayano Fukushima-Nomura, et al.
Medicine|December 10, 2021
Imatinib mesylate in combination with pembrolizumab in patients with advanced KIT-mutant melanoma following progression on standard therapy: A phase I/II trial and study protocolIkuko Hirai, Keiji Tanese, Keitaro Fukuda, et al.
Pageof 6